Sachi Sakaguchi
Eli Lilly (Japan)(JP)
Publications by Year
Research Areas
Advanced Breast Cancer Therapies, Childhood Cancer Survivors' Quality of Life, Chronic Lymphocytic Leukemia Research, Cancer-related Molecular Pathways, HER2/EGFR in Cancer Research
Most-Cited Works
- → A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer(2015)270 cited
- → Effects of NaCl application to hydroponic nutrient solution on fruit characteristics of tomato (Lycopersicon esculentum Mill.)(2006)116 cited
- → Bacterial rRNA-Targeted Reverse Transcription-PCR Used To Identify Pathogens Responsible for Fever with Neutropenia(2010)62 cited
- → Involvement of insulin-like growth factor-I and insulin-like growth factor binding proteins in pro–B-cell development(2006)33 cited
- → Characteristics of interstitial lung disease in patients from post-marketing data on metastatic breast cancer patients who received abemaciclib in Japan(2021)25 cited
- → Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that progressed on endocrine therapy(2021)24 cited
- → Abemaciclib in combination with endocrine therapy for East Asian patients with HR+, HER2− advanced breast cancer: MONARCH 2 & 3 trials(2021)24 cited
- → Secondary cancers among children with acute lymphoblastic leukaemia treated by the Tokyo Children's Cancer Study Group protocols: a retrospective cohort study(2013)22 cited
- → Pregnant Women’s Perception of Risk With Use of the H1N1 Vaccine(2011)20 cited
- Effect of methotrexate treatment of ectopic pregnancy on subsequent pregnancy.(2011)